Active	Status	Sponsor type	Region	Phase	Filter
10 Active 3 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Barbara, Giovanni
NCT05016024: Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.	Completed	N/A	71	Europe	Colilen IBS, Placebo	Aboca Spa Societa' Agricola, IQVIA RDS, IQVIA Solutions	Irritable Bowel Syndrome	02/23	02/23
GIANT, NCT06681012: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome	Recruiting	N/A	330	Europe	Gelsectan®, Placebo	Devintec Sagl	Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)	11/25	11/25
Gambineri, Alessandra
NCT06484868: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy	Recruiting	4	12	Europe	Metreleptin	Amryt Pharma	Partial Lipodystrophy	09/27	09/27
MEASuRE, NCT02325674: Metreleptin Effectiveness And Safety Registry	Recruiting	N/A	100	Europe, US	Metreleptin	Aegerion Pharmaceuticals, Inc.	Generalised Lipodystrophy, Partial Lipodystrophy	10/31	10/31

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Barbara, Giovanni
NCT05016024: Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.	Completed	N/A	71	Europe	Colilen IBS, Placebo	Aboca Spa Societa' Agricola, IQVIA RDS, IQVIA Solutions	Irritable Bowel Syndrome	02/23	02/23
GIANT, NCT06681012: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome	Recruiting	N/A	330	Europe	Gelsectan®, Placebo	Devintec Sagl	Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)	11/25	11/25
Gambineri, Alessandra
NCT06484868: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy	Recruiting	4	12	Europe	Metreleptin	Amryt Pharma	Partial Lipodystrophy	09/27	09/27
MEASuRE, NCT02325674: Metreleptin Effectiveness And Safety Registry	Recruiting	N/A	100	Europe, US	Metreleptin	Aegerion Pharmaceuticals, Inc.	Generalised Lipodystrophy, Partial Lipodystrophy	10/31	10/31